Pharma & Biotech

The stock performance of artificial intelligence healthcare company Tempus AI has become a focal point for investor debate this year....

Biotechnology firm Altimmune is witnessing a substantial rally in its share price following the release of impressive mid-stage clinical trial...

Biopharmaceutical firm Ocugen presents investors with a classic dilemma: promising clinical developments in gene therapy set against a backdrop of...

Genetic testing specialist Natera has delivered a quarterly report that significantly surpassed market forecasts, propelling its stock upward. The company...

Pharmaceutical giant Eli Lilly has made a decisive move in its corporate benefits strategy, immediately dropping CVS Health as its...

Novo Nordisk's stock is showing signs of life after a prolonged downturn, but investors remain divided on whether this represents...

The independent journey of Allakos as a publicly traded biopharmaceutical firm has concluded following its acquisition by Concentra Biosciences. Shareholders...

Investors are rallying behind BioNTech stock despite the company's recent quarterly loss, signaling a potential turnaround for the vaccine developer....

The Canadian biotechnology firm BioNxt Solutions has reached a significant corporate milestone, receiving positive notifications from two major patent authorities....

Investors have responded with strong approval to Novo Nordisk's latest strategic maneuver in the Indian pharmaceutical market. The Danish pharmaceutical...